AMPK is a critical signaling pathway involved in inhibiting hepatic de novo lipogenesis and increasing fatty acid oxidation and insulin sensitivity, but the controversial role of this signaling in AMPK-FXR crosstalk, which induces cholestasis and hepatotoxicity, has been reported [37,42]. This evidence concerns the gene NR1H4 and cholestasis.